Sprycel®
Showing 1 - 25 of >10,000
Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole
Completed
- Drug-drug Interaction Study
- SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
-
Hyderabad, IndiaQPS Bioserve India Pvt Limited
Nov 20, 2023
Biological Availability Trial in Hyderabad (Dasatinib ASD 100 mg, Dasatinib 140 MG [Sprycel])
Completed
- Biological Availability
- Dasatinib ASD 100 mg
- Dasatinib 140 MG [Sprycel]
-
Hyderabad, IndiaQPS Bioserve India Pvt Limited
Jun 28, 2022
Leukemia, Myelogenous, Chronic Trial in Changchun (CTTQ Dasatinib tablet, Sprycel Dasatinib tablet)
Completed
- Leukemia, Myelogenous, Chronic
- CTTQ Dasatinib tablet
- Sprycel Dasatinib tablet
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Dec 7, 2022
Myeloma Multiple Trial in Chia (Dasatinib 100 MG)
Not yet recruiting
- Myeloma Multiple
- Dasatinib 100 MG
-
Chia, Cundinamarca, ColombiaCAIMED
Jul 12, 2023
Osteopenia, Osteoporosis Trial in Odense (Dasatinib 100 Mg Oral Tablet, Quercetin 1.250 mg (oral), Nicotinamide Riboside 1g
Recruiting
- Osteopenia, Osteoporosis
- Dasatinib 100 Mg Oral Tablet
- +2 more
-
Odense, DenmarkOdense University Hospital
Aug 29, 2023
Stem Cell Transplant Trial in Rochester (Quercetin, Standard of Care - Observation Only, Dasatinib)
Recruiting
- Stem Cell Transplant
- Quercetin
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 18, 2022
Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)
Completed
- Advanced Cancer
- Dasatinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 21, 2022
Advanced Cancers Trial in Houston (Crizotinib, Dasatinib)
Completed
- Advanced Cancers
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 29, 2022
Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 6, 2022
Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Dasatinib Pill
- Ketoconazole Pill
-
Monterrey, Nuevo Leon, MexicoHospital Universitario Dr. José Eleuterio González
Nov 25, 2022
Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)
Recruiting
- Waldenstrom Macroglobulinemia
- DASATINIB
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 22, 2022
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)
Terminated
- Rhabdomyosarcoma
- +2 more
-
Los Angeles, California
- +1 more
Mar 17, 2022
Chronic Kidney Disease Trial in Rochester (Group 2: Dasatinib, Group 2: Quercetin)
Enrolling by invitation
- Chronic Kidney Disease
- Group 2: Dasatinib
- Group 2: Quercetin
-
Rochester, MinnesotaMayo Clinic in Rochester
May 14, 2022
Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Dasatinib, Cytarabine, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Dasatinib
- +3 more
-
Innsbruck, Austria
- +53 more
Sep 19, 2022
Frailty, Childhood Cancer Trial in Memphis (Dasatinib plus Quercetin, Fisetin)
Recruiting
- Frailty
- Childhood Cancer
- Dasatinib plus Quercetin
- Fisetin
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 8, 2022
Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)
Active, not recruiting
- Malignant Pleural Mesothelioma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 25, 2022
Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)
Active, not recruiting
- Prostate Cancer
- degarelix
- +3 more
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Aug 25, 2022
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Trial in Valencia (dasatinib)
Completed
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
-
Valencia, SpainHospital La Fe
Mar 16, 2022
Breast Tumors, Triple Negative Breast Tumors Trial in Chicago, Madison (drug, procedure, other)
Terminated
- Breast Neoplasms
- Triple Negative Breast Neoplasms
- Dasatinib
- +2 more
-
Chicago, Illinois
- +1 more
Jun 2, 2022
B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- ABL001
- +2 more
-
Chicago, Illinois
- +5 more
Dec 27, 2021
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)
Not yet recruiting
- Refractory Acute Lymphoblastic Leukemia
- Relapsed Acute Lymphoblastic Leukemia
- Venetoclax
- +16 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 23, 2022
Breast Cancer, Bone Metastases Trial in Chicago, Durham, Houston (Dasatinib, Zoledronic Acid)
Completed
- Breast Cancer
- Bone Metastases
- Dasatinib
- Zoledronic Acid
-
Chicago, Illinois
- +2 more
Feb 2, 2022